Dinamiche Respiratorie e in Tempo Reale nel Movimento Paradossale delle Corde Vocali Indotto dall'Esercizio (EILO)
Dinamiche Respiratorie e in Tempo Reale nel Movimento Vocale Paradosso Indotto da Esercizio
The overall objectives of the proposed research are to:
- Evaluate the diagnostic validity of a novel mechano-acoustic signatures of task-characteristic activity during symptomatic and asymptomatic breathing in Exercise-Induced Laryngeal Obstruction (EILO) patients with the use of a novel miniature, soft wearable skin-mounted device,
- Identify the mechanism/s of paradoxical respiratory control in EILO by quantifying the relationship between pulmonary mechanics, partial pressure of carbon dioxide (PCO2) maintenance, and vocal fold aperture prior to and during symptomatic and asymptomatic exercise ventilation, and
- Identify unique biophysiological factors contributing to EILO among exercisers with and without EILO. Findings will be highly novel and clinically significant for early identification and management of EILO.
The main study will enroll 60 participants with EILO and 60 without EILO to complete three separate visits:
- Exercise treadmill study
- Free running with the device on the neck
- Undergoing MRI (Magnetic Resonance Imaging) of the vocal tract.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Main Study
At the first study visit, participants will sign informed consent, complete study questionnaires, have their height, weight, and body composition measured, and perform resting pulmonary function tests. Participants will then warm up on the treadmill for 10 minutes. An endoscope will be placed in one nostril until the vocal folds are visible, and subjects will be fitted with a chest strap heart rate monitor, an oro-nasal face mask, and the mechanoacoustic device. This sensor is placed on the neck with a velcro band. Participants will then undergo a graded exercise test during which a carbon-dioxide enriched gas mixture will be administered. The amount of the gas mixture will be titrated based on measures of the participant's breathing and lung function. This visit will be video recorded.
At the second study visit, participants will be asked to again wear the mechanoacoustic device while free running for 10 minutes in a large room or on a track. This visit will be video-recorded.
At the third study visit, participants will be asked to undergo an MRI scan, during which they will perform a variety of breathing exercises including rest breathing, rapid breathing, pursed lip breathing, sniff, and open mouth breathing. Research personnel will instruct participants in the various breathing techniques prior to the scan.
The study visits may occur in any order.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Fase 2
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Rita R Patel
- Numero di telefono: 812-855-3886
- Email: patelrir@iu.edu
Luoghi di studio
-
-
Indiana
-
Bloomington, Indiana, Stati Uniti, 47401
- Reclutamento
- Indiana University
-
Contatto:
- Rita Patel
- Numero di telefono: 812-855-3886
- Email: patelrir@iu.edu
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria for Exercise-Induced Laryngeal Obstruction (EILO):
- Physically active >2.5 hours per week
- Patients with EILO, as diagnosed by routine clinical examination by physician and/or speech language pathologist
- Age range of 18-26 years
- Greater difficulty breathing inside compared to out and difficulty breathing which is exacerbated at peak exercise and stops 1-5 minutes after exercise
- Score of 7 or higher on the Dyspnea Index, which is a validated instrument to capture participant self-report of upper airway dyspnea symptoms.
- Classified as low risk, based on the modified Physical Activity Readiness Questionnaire (PAR-Q) questionnaire, body mass index, and non-smoking status
- Negative history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
- No metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.
Inclusion Criteria for Controls
- Physically active >2.5 hours per week
- Age range of 18-26 years
- Classified as low risk, based on the modified PAR-Q questionnaire, body mass index, and non-smoking status
- Negative history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
- No metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.
Exclusion Criteria for EILO:
- Individuals older than 26 years and younger than 18 years of age.
- Women who are pregnant or could possibly be pregnant.
- A 'yes' answer to any of the 14 questions on the PAR-Q pre-participation questionnaire
- Current smoker
- Positive history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
- Presence of metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.
- Do not report the following: Greater difficulty breathing inside compared to out and difficulty breathing which is exacerbated at peak exercise and stops 1-5 minutes after exercise
Exclusion Criteria for Controls
- Individuals older than 26 years and younger than 18 years of age.
- Women who are pregnant or could possibly be pregnant.
- A 'yes' answer to any of the 14 questions on the PAR-Q pre-participation questionnaire
- Current smoker
- Positive history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
- Presence of metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.
- Significant acute or chronic medical, neurologic, or illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Comparatore attivo: EILO Participants
|
Breathing Hypercapnic Gas (10% CO2 (carbon dioxide) and 21%O2 (oxygen), balance N210% (nitrogen)) A custom developed mechanoacoustic sensor will be worn on the neck using a Velcro strap. The device will collect audio recordings of breathing and breath sounds and will collect muscle activity from the neck muscles. |
|
Comparatore attivo: Control Participants
Participants without Exercise-induced laryngeal obstruction (EILO). |
Breathing Hypercapnic Gas (10% CO2 (carbon dioxide) and 21%O2 (oxygen), balance N210% (nitrogen)) A custom developed mechanoacoustic sensor will be worn on the neck using a Velcro strap. The device will collect audio recordings of breathing and breath sounds and will collect muscle activity from the neck muscles. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Device measurements from real time running
Lasso di tempo: Baseline and Periprocedural
|
Muscle activation of cricothyroid/sternohyoid muscle measured via customized surface electromyography amplifier |
Baseline and Periprocedural
|
|
Device measurements from real time running
Lasso di tempo: Baseline and Periprocedural
|
Normalized amplitude (100% of maximum voluntary contraction) Burst duration (milliseconds) prior to and during Exercise-Induced Laryngeal Obstruction event of laryngeal closure. |
Baseline and Periprocedural
|
|
Device measurements from real time running
Lasso di tempo: Baseline and Perioprocedural
|
Exercise-Induced Laryngeal Obstruction signature detected via ultra-low noise micro-electromechanical (MEMS) microphone amplitude (dB) prior to and during EILO. EILO signature detected via accelerometer (g, where g represents the gravitational acceleration of 9.8 m/s2) prior to and during EILO |
Baseline and Perioprocedural
|
|
Treadmill testing
Lasso di tempo: Baseline and Perioprocedural
|
Breathing frequency (breaths per minute) |
Baseline and Perioprocedural
|
|
Treadmill testing
Lasso di tempo: Baseline
|
Tidal volume (Liters) |
Baseline
|
|
Treadmill testing
Lasso di tempo: Breath-by-breath baseline and Perioprocedural
|
Ventilation (Liters/minute) |
Breath-by-breath baseline and Perioprocedural
|
|
Treadmill testing
Lasso di tempo: Baseline and Periprocedural
|
Partial pressure of arterial carbon dioxide estimated from end-tidal partial pressure of carbon dioxide; PetCO2) (mmHg) |
Baseline and Periprocedural
|
|
MRI Upper Airway Size
Lasso di tempo: Baseline
|
Length (mm), width (mm), and cross-sectional area (mm2) of oropharynx, supraglottis, glottis, immediate subglottis. |
Baseline
|
|
Upper Airway Aerodynamics
Lasso di tempo: Baseline and Periprocedural
|
pressure (Pa) across oropharynx, supraglottis, and subglottis |
Baseline and Periprocedural
|
|
Upper Airway Aerodynamics
Lasso di tempo: Baseline and Periprocedural
|
volume flow rate (l/s) across oropharynx, supraglottis, and subglottis |
Baseline and Periprocedural
|
|
Upper Airway Aerodynamics
Lasso di tempo: Baseline and Periprocedural
|
flow velocities (m/s) across oropharynx, supraglottis, and subglottis |
Baseline and Periprocedural
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Self-rating of dyspnea
Lasso di tempo: Baseline
|
Participants will rate breathing intensity and breathing unpleasantness on a Visual Analog Scale of 0 to 100mm, where 0 indicates not at all and 100 indicates maximal imaginable intensity/unpleasantness. |
Baseline
|
|
Profile of Mood States (POMS)
Lasso di tempo: Baseline
|
The POMS will be used to evaluate the participants' mood and to better understand how the emotional state relates to physical responses during testing. The POMS measures different aspects of mood on a 5-point Likert scale from 0 (not at all) to 4 (extremely). |
Baseline
|
|
Menstrual Screening Questionnaire
Lasso di tempo: Baseline
|
Female participants will complete a screening questionnaire about menstruation history and use of hormonal birth control which will be used to evaluate the relationship between EILO and menstruation. |
Baseline
|
|
Pittsburgh Sleep Quality Index (PSQI)
Lasso di tempo: Baseline
|
The PSQI will be used to evaluate the relationship between sleep and exercise. Total PSQI scores range from 0 to 21 with lower scores indicating better sleep quality. |
Baseline
|
|
International Physical Activity Questionnaire (IPAQ)
Lasso di tempo: Baseline
|
Participants will complete the IPAQ which collects information on the frequency and duration of physical activities. |
Baseline
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Rita Patel, Indiana University
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 29009
- R01DC023381 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
The data will be available indefinitely, as per NIH's Data Management and Sharing Policy to maximize the appropriate sharing of scientific data.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
- CODICE_ANALITICO
- RSI
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .